Literature DB >> 9449045

IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth.

Y Oh1.   

Abstract

The insulin-like growth factor binding proteins (IGFBPs) are a family of seven structurally homologous proteins that bind insulin-like growth factor 1 (IGF-I) and IGF-II with high affinity, thereby modu-lating the actions of IGFs. Several lines of recent evidence from various cell systems have suggested that IGFBPs, especially IGFBP-3, may play more active, IGF-independent, roles in growth regulation of cancer cells. In support of this hypothesis, the author has recently shown that IGFBP-3 binds specifically and with high affinity to the surface of various cell types and directly inhibits monolayer growth of these cells in an IGF-independent manner, presumably by specific interaction with cell membrane proteins that function as an IGFBP-3 receptor. The author's current studies demonstrate that a new class of IGFBP, IGFBP-7, constitutes a low affinity member of the IGFBP family, but primarily functions as a modulator of cell growth in an IGF-independent manner, similar to the action observed with IGFBP-3 in breast cancer cells. The author's studies on the mechanisms of action of the low affinity IGFBPs will provide insight into the IGF-independent actions of the classical high affinity IGFBPs and their impact on cancer cell growth.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9449045     DOI: 10.1007/BF02778076

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  29 in total

Review 1.  Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.

Authors:  W H Daughaday; P Rotwein
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

Review 2.  Binding proteins for the insulin-like growth factors: structure, regulation and function.

Authors:  R C Baxter; J L Martin
Journal:  Prog Growth Factor Res       Date:  1989

3.  Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells.

Authors:  F Capony; C Rougeot; P Montcourrier; V Cavailles; G Salazar; H Rochefort
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

4.  Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins.

Authors:  R C Baxter; J L Martin; M I Tyler; M E Howden
Journal:  Biochem Biophys Res Commun       Date:  1986-09-30       Impact factor: 3.575

Review 5.  New concepts in insulin-like growth factor receptor physiology.

Authors:  Y Oh; H L Müller; E K Neely; G Lamson; R G Rosenfeld
Journal:  Growth Regul       Date:  1993-06

6.  Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status.

Authors:  J A Figueroa; J G Jackson; W L McGuire; R F Krywicki; D Yee
Journal:  J Cell Biochem       Date:  1993-06       Impact factor: 4.429

7.  Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells.

Authors:  H Huynh; X Yang; M Pollak
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

8.  Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid.

Authors:  K Swisshelm; K Ryan; K Tsuchiya; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Induction of the growth inhibitor IGF-binding protein 3 by p53.

Authors:  L Buckbinder; R Talbott; S Velasco-Miguel; I Takenaka; B Faha; B R Seizinger; N Kley
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

10.  Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure.

Authors:  D Y Lee; S K Park; P D Yorgin; P Cohen; Y Oh; R G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1994-11       Impact factor: 5.958

View more
  7 in total

1.  Normal IGF-I and enhanced IGFBP-3 response to very low rhGH dose in patients with dilated cardiomyopathy.

Authors:  F Broglio; A Benso; E Arvat; G Aimaretti; C Gottero; R Granata; M F Boghen; M Bobbio; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  Expression levels of insulin-like growth factors 1 and 2 in head and neck squamous cell carcinoma.

Authors:  Xu Zhi; Katarzyna Lamperska; Paweł Golusinski; Nicholas J Schork; Lukasz Luczewski; Wojciech Golusinski; Michal M Masternak
Journal:  Growth Horm IGF Res       Date:  2014-04-22       Impact factor: 2.372

3.  Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3.

Authors:  Thorsten Sadowski; Sebastian Dietrich; Felix Koschinsky; Radislav Sedlacek
Journal:  Mol Biol Cell       Date:  2003-08-22       Impact factor: 4.138

4.  Insulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer.

Authors:  E Nardon; I Buda; G Stanta; E Buratti; M Fonda; L Cattin
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

5.  Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients.

Authors:  Carlos Fernández-Pereira; Maria Aránzazu Penedo; Tania Rivera-Baltanas; Rafael Fernández-Martínez; Saida Ortolano; José Manuel Olivares; Roberto Carlos Agís-Balboa
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

6.  Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer.

Authors:  Anastassios Philippou; Athanasios Armakolas; Michael Koutsilieris
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-20       Impact factor: 5.555

7.  Effects of HLEC on the secreted proteins of epithelial ovarian cancer cells prone to metastasize to lymph nodes.

Authors:  Xin-Ying Zhang; Fu-Qiang Yin; Li Liu; Ting Gao; He-Yun Ruan; Xiao Guan; Ying-Xin Lu; Dan-Rong Li
Journal:  Cancer Biol Med       Date:  2013-12       Impact factor: 4.248

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.